Clinical trial
Pirfenidone for Progressive Fibrotic Sarcoidosis
NCT03260556 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pirfenidone for Progressive Fibrotic Sarcoidosis
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 27, 2017
- Completion date
- March 30, 2020
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.